Benchmark Reiterates Buy Rating for Magnite (NASDAQ:MGNI)
Magnite (NASDAQ:MGNI – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Benchmark in a research note issued on Wednesday, Benzinga reports. They presently have a $21.00 price target on the stock. Benchmark’s price objective would indicate a potential upside of 71.71% from the stock’s previous close. Several other analysts have […]
More Stories
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Recommendation of “Buy” from Brokerages
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has been assigned a consensus rating of “Buy” from the eight research...
Lamine Yamal Net Worth: How Much Does Spain’s Youngest Footballer Earn?
A professional Spain’s youngest footballer, Lamine Yamal, is often known for his playing stints, and the impressive salary he earns....
Analysts Set Larimar Therapeutics, Inc. (NASDAQ:LRMR) PT at $20.00
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) has been given a consensus rating of “Buy” by the nine ratings...
PennantPark Investment Co. (PNNT) to Issue Monthly Dividend of $0.08 on November 1st
PennantPark Investment Co. (NASDAQ:PNNT – Get Free Report) declared a monthly dividend on Wednesday, October 2nd, Wall Street Journal reports....
Global X SuperDividend REIT ETF (NASDAQ:SRET) to Issue Monthly Dividend of $0.16
Global X SuperDividend REIT ETF (NASDAQ:SRET – Get Free Report) declared a monthly dividend on Wednesday, October 2nd, NASDAQ reports....
Cohen & Steers Select Preferred and Income Fund, Inc. (PSF) to Issue Monthly Dividend of $0.13 on November 29th
Cohen & Steers Select Preferred and Income Fund, Inc. (NYSE:PSF – Get Free Report) announced a monthly dividend on Wednesday,...